WCG Talks Trials
By WCG
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by WCG
Category: Life Sciences
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 0
Reviews: 0
Episodes: 86
Description
Insights from leaders in clinical research and trial optimization, hosted by the WCG Clinical.
| Episode | Date |
|---|---|
|
Health Literacy in Action: The Impact of Plain Language Communication in Clinical Research
|
Oct 09, 2025 |
|
Advancing Access: How SaaS is Transforming Clinical Trials
|
Aug 26, 2025 |
|
Advancing Imaging in Clinical Trials Using AI
|
Aug 06, 2025 |
|
Future-Ready Research: Optimizing Sites for Continued Success
|
Jun 20, 2025 |
|
Harnessing Generative AI in Clinical Research
|
May 28, 2025 |
|
AI in Clinical Trials: Unlocking the Potential
|
Mar 18, 2025 |
|
Breaking Down Site Complexities and Start-Up Barriers in Clinical Trials
|
Feb 24, 2025 |
|
From Patient Care to Discovery: A Clinician's Journey into Research
|
Dec 10, 2024 |
|
Inside MAGI: Innovation, Education, and Industry Trends
|
Nov 25, 2024 |
|
Revolutionizing Clinical Research Through Collaboration and Innovation
|
Nov 07, 2024 |
|
Have a Safe Trip: Clinical and Patient Alignment in Research with Psychedelics
|
Oct 07, 2024 |
|
Breaking Barriers: Reasons to Expand Site Cancer Trial Portfolios
|
Sep 18, 2024 |
|
Patient Advocacy Advancing Breakthrough Science and Community Engagement
|
Sep 16, 2024 |
|
Guarding Research Integrity: The IRB's Essential Role
|
Sep 13, 2024 |
|
Addressing Challenges in Site Feasibility
|
Aug 30, 2024 |
|
Ethical Review and AI in Clinical Trials
|
Jun 21, 2024 |
|
Addressing Measurement Challenges for PTSD Trials with Technology
|
Jun 11, 2024 |
|
What Is E-Consent? Interview with Erin Brower
|
Apr 11, 2024 |
|
Creating Partnerships: Aligning Vendor Support for Success in Clinical Research
|
Mar 06, 2024 |
|
WCG's IRB Policy Change: Harmonizing Consent (Part 2)
|
Feb 27, 2024 |
|
WCG's IRB Policy Change: Harmonizing Consent (Part 1)
|
Feb 27, 2024 |
|
The Ethical and Safety Considerations of Accelerating Oncology Trials
|
Jan 16, 2024 |
|
Embarking on a Research Revolution – A Conversation with Florence Healthcare
|
Dec 18, 2023 |
|
The CRA’s Evolving Role in a Postpandemic Industry
|
Dec 14, 2023 |
|
MAGI@home: Practical Intelligence, Real-life Examples, Actionable Information
|
Dec 04, 2023 |
|
Diversity & Inclusion with Technology in Decentralized Trials
|
Nov 22, 2023 |
|
Amplifying Patient Voices to Advance Clinical Research: The Importance of Patient Advocacy
|
Nov 13, 2023 |
|
The Importance of Diversity, Equity, Inclusion, and Intersectionality in Clinical Research
|
Oct 27, 2023 |
|
Delve into the World of Psychedelic Research and Ethical Inquiry
|
Sep 26, 2023 |
|
A 360-degree View on Motivators and Deterrents to Clinical Trial Participation
|
Sep 11, 2023 |
|
Breaking Down Enrollment Barriers: How DE&I, Technology, and Protocol Design Impact Enrollment Success
|
Aug 16, 2023 |
|
Unlocking Site Potential: Reducing Site Burden and Enhancing Clinical Trial Efficiency
|
Jul 16, 2023 |
|
Connecting Patients to Trials: Bernadette Siddiqi of The Michael J. Fox Foundation for Parkinson’s Research
|
Dec 16, 2020 |
|
On the Future of Movement Disorder Trials: Part 4 of WCG’s Transforming CNS Trials Series
|
Oct 21, 2020 |
|
Prostate Cancer Survivor Bryce Olson’s Message: “Sequence Me!”
|
Oct 08, 2020 |
|
On the Future of Depression Trials: Part 3 of WCG’s Transforming CNS Trials Series
|
Sep 30, 2020 |
|
LaTasha H. Lee, PhD, MPH: Advocating for Health Equity, Advancing Sickle Cell Disease Research
|
Sep 29, 2020 |
|
Jeffrey Borghoff: Finding Joy and Purpose after an Early-Onset Alzheimer’s Diagnosis
|
Sep 24, 2020 |
|
On the Future of Schizophrenia Trials: Part 2 of WCG’s Transforming CNS Trials Series
|
Sep 21, 2020 |
|
Lisa Deck: Young Stroke Survivor Transforms Life-Altering Challenge into Purpose-Driven Advocacy for Others
|
Sep 16, 2020 |
|
The Case for Centralized Monitoring: Optimizing Data Quality and Risk Management with Linda Sullivan and Steve Young
|
Aug 31, 2020 |
|
Michael Poku, MD, MBA: Improving Minority Representation in Clinical Trials
|
Aug 28, 2020 |
|
Dana Deighton: Esophageal Cancer Patient and Persistent Activist For Her Own Survival
|
Aug 27, 2020 |
|
Striving for Reliability: Optimizing Patient Report Data through World-Class Design Management with Linda Sullivan, Nat Katz, and Art Morales
|
Aug 27, 2020 |
|
The Upside of Centralized Monitoring During a Pandemic: Linda Sullivan, Duncan Hall, and Rachel Oakley on Optimizing Clinical Trials through Innovative RBQM Technology
|
Aug 19, 2020 |
|
Get Rid of Those Silos: Linda Sullivan, Artem Andrianov, and Johann Proeve on How To Optimize Clinical Trials through RBQM
|
Aug 17, 2020 |
|
Gregory L. Hall, MD: Writing the Book on Health Disparities in African Americans
|
Jul 30, 2020 |
|
Turning Insights Into Action: Linda Sullivan and Ken Getz on How Metrics and Benchmarking Provide a Path To Optimizing Clinical Trials
|
Jul 29, 2020 |
|
Lisa Carlton, PhD: Fighting Rare Diseases as a Mother, Patient Advocate and Regulatory Affairs Professional
|
Jul 29, 2020 |
|
Peter A. DiBiaso, MHA: Taking on the Ironman, Mount Kilimanjaro and Parkinson’s disease: a clinical trials patient recruitment expert speaks about his own life as a patient
|
Jul 29, 2020 |
|
Now Is the Time: Making Your Clinical Trial More Resilient
|
Jul 24, 2020 |
|
Hong Liu, PhD, Making Chicago a Healthier City for Asian Americans
|
Jul 21, 2020 |
|
Roslyn Daniels, Black Health Matters Founder and President, on Health Disparities and Exciting Communities About Health
|
Jul 08, 2020 |
|
Dorelia Rivera: Health Disparities, a Career in Advocacy, and Saving Her Daughter’s Life
|
Jun 12, 2020 |
|
Christopher Gantz, Building Trust and minority enrollment in clinical trials at Thomas Jefferson Hospital in Philadelphia
|
Jun 12, 2020 |
|
Communicating the Value of Clinical Trials to Underserved Minority Communities
|
Jun 08, 2020 |
|
People, Process and Technology: The Right Combination for Successful Expert Committees
|
Jun 03, 2020 |
|
Bringing Clinical Trials Closer to Home: Smaller, Local Sites Build Trust & Provide Access to Local Communities
|
May 15, 2020 |
|
Raise Your Voices: Social Network Provides Safe Place for Patients to Share Stories and Influence Research
|
May 06, 2020 |
|
Brian Loew, The INSPIRE social network platform provides a safe place for patients to meet, learn, and influence research
|
Apr 28, 2020 |
|
Frank Sasinowski, MS, MPH, JD Hymen Phelps & McNamara: Rare Disease Regulatory Transformation: 1983 AIDS Crisis to Present
|
Apr 28, 2020 |
|
Thomas Farrington: Cancer Survivor’s Prostate Health Network gets African American Communities Talking About Prostate Cancer
|
Apr 21, 2020 |
|
We Should Not Be Surprised: COVID-19 Disparities Lay Bare What’s Been There All Along
|
Apr 17, 2020 |
|
COVID-19 Doesn’t Play Fair: What We Need to Understand About Racial Disparities
|
Apr 15, 2020 |
|
Dr. David Fajgenbaum, MD, Castleman’s Disease Survivor, Facing COVID-19 with Research, Action, and Hope
|
Apr 01, 2020 |
|
Turning Passion Into a Career: Insights from a Physician and Industry Medical Director of AbbVie Pharmaceuticals, Charlotte Owens, MD, FACOG
|
Feb 24, 2020 |
|
An Inside Look at the Role of Data Monitoring Committees with Dr. Jonathan Seltzer
|
Feb 13, 2020 |
|
Biostatistics and Biomarkers for the Reliability and Efficiency of Clinical Trials: A Conversation with Dr. Janet Wittes
|
Feb 13, 2020 |
|
An Interview with Dr. Jeffrey Cooper: Clinical Trial Expert and Participant
|
Feb 10, 2020 |
|
Julia Jenkins, EveryLife Foundation for Rare Diseases: Patient’s shape science-driven public policy
|
Feb 10, 2020 |
|
Ensuring Genetic Counseling is Incorporated Into the Patient Experience: An Interview with Sarah Zentack & Leslie Urdaneta
|
Jan 13, 2020 |
|
Learning How to See Differently: An Interview with Kristin Smedley, President of the Curing Retinal Blindness Foundation
|
Jan 13, 2020 |
|
The Role and Importance of Genetic Counselors to Patients: An Interview with Karmen Trzupek of InformedDNA
|
Jan 13, 2020 |
|
An Inside Look at Angelman Syndrome Rare Disease: An Interview with Amanda Moore
|
Jan 13, 2020 |
|
Blazing New Trails in Rare Disease & CNS Clinical Studies: An Interview with Dr. Mark Opler
|
Jan 13, 2020 |
|
Developing Novel Treatments for Rare Disorders: A Look at MPS I with Dr. Emil Kakkis
|
Jan 13, 2020 |
|
Mark Dant, Pushing for Research that Saved His Son’s Life in the Fight Against MPS I
|
Jan 13, 2020 |
|
Sarah Tompkins, on Having Ehlers-Danlos Syndrome, Having a Mis-Understood Disease, and Taking a Lead in Advocacy
|
Jan 13, 2020 |
|
Chasing My Cure: an Interview with Dr. Fajgenbaum
|
Nov 18, 2019 |
|
The State of Clinical Trials in Autism and Neurodevelopmental Disorders with Dr. Scott Hunter
|
Aug 13, 2019 |
|
The New Paradigm of Patient Recruitment: an interview with Mark Summers
|
Jul 05, 2019 |
|
Exciting Developments in Psychopharmacology with guest Andrew Cutler, MD
|
May 02, 2019 |
|
The Role of Expert Committees in Clinical Research with guest Jonathan Seltzer, MD, MBA, MA, FACC
|
Apr 27, 2019 |
|
The Most Pressing Challenges and Opportunities in Pain Research with guest Nathaniel Katz, MD, MS
|
Apr 18, 2019 |
|
Important Trends in CNS Clinical Trials with guest Cristoph Correll, MD
|
Mar 27, 2019 |
|
The Most Pressing Challenges in Psychiatry Clinical Trials with Leslie Citrome, MD, MPH
|
Mar 06, 2019 |